Condensed Consolidated Statements of Income (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Revenues (premium equivalents of $99,407 and $78,548 for the three months ended September 30, 2017 and 2016, respectively and $289,243 and $226,265 for the nine months ended September 30, 2017 and 2016, respectively)	$ 63,335	$ 46,108	$ 180,986	$ 133,092
Operating expenses:
Third-party commissions	36,603	25,860	103,146	77,709
Credit card and ACH fees	1,289	921	3,704	2,778
Selling, general and administrative	15,503	11,853	45,457	35,520
Depreciation and amortization	1,028	835	2,958	2,367
Total operating expenses	54,423	39,469	155,265	118,374
Income from operations	8,912	6,639	25,721	14,718
Other expense:
Interest (income) expense	(2)	(102)	(2)	53
Tax Receivable Agreement expense	0	0	0	429
Fair value adjustment to contingent acquisition consideration	0	0	0	15
Other expense	23	27	27	30
Income before income taxes	8,891	6,714	25,696	14,191
Provision for income taxes	2,889	1,580	4,220	2,501
Net income	6,002	5,134	21,476	11,690
Net income attributable to noncontrolling interests	2,117	3,195	7,374	6,989
Net income attributable to Health Insurance Innovations, Inc.	$ 3,885	$ 1,939	$ 14,102	$ 4,701
Net income per share attributable to Health Insurance Innovations, Inc.
Basic (in USD per share)	$ 0.33	$ 0.25	$ 1.31	$ 0.62
Diluted (in USD per share)	$ 0.30	$ 0.25	$ 1.21	$ 0.61
Weighted average Class A common shares outstanding
Basic (in shares)	11,700,941	7,614,252	10,724,750	7,590,347
Diluted (in shares)	12,742,952	7,723,196	11,692,755	7,724,168